In fact, it is not a surgery, but a procedure in the Office entailed, then drawing blood from his arm, spun in a centrifuge to separate the platelets. They are then injected into your face, hoping to stimulate new collagen production. Selphyl, as it is called the system arrived in the burgeoning market of rejuvenation in 2009 and which is now used by about 300 doctors around the country on behalf of the beauty, said Sanjay Batra, Executive Director of aesthetic factors, which manufactures the Selphyl system.
This year, the "Lifting vampire" has been promoted in "the rachael ray show" and "The doctors". It has also got air time in local news from more than a dozen, some of which have proven claims that results will be the last two years.
Dr. Drew Ordon, one of the hosts of "the doctors" and a certified plastic surgeon, sprouted in the air, "vampires have moved to plastic surgery, too, and I am one of them." The patient in its segment has also recently had its own fat injected into his pudgy face, so it was not clear that platelets had something to do with its fresher appearance. (Not that stops the applause of the public.)
Macabre as the sounds of procedure, some patients prefer the idea of using his own blood rather than a neurotoxin or synthetic filler to rejuvenate their faces. "All we want to see better," said Joan Sarlo, 56, suffered a Selphyl "vampiresa-ascensor" by Dr. Lisa a. Zdinak, a doctor based in Manhattan, whose specialty is the eye-surgery. But the "less unnatural," said Ms. Sarlo. "What could be better than the own blood?"
Some doctors say that stuffed body are less likely to cause irregularities and blows in areas sensitive to synthetic as Sculptra aesthetic. But at the moment, it is difficult to say if the "platelet-rich fibrin matrix", or P.R.F.M. (the medical term for platelets of gold hued extracted from Selphyl), is a filler effective to hollowed cheeks and wrinkles.
Dr. Anthony p. Sclafani, the director of facial plastic surgery in the eye of New York and Ear Infirmary, said he has seen the tonic effects of P.R.F.M. on patients cosmetics last for more than a year, sometimes from 18 to 24 months. (Dr. Sclafani is a consultant paid by aesthetic factors, and most of his research on Selphyl has been funded by the company).
But no national clinical trials had been done to prove these claims. "There isn't any data target out there to support the claim of two years," Dr. Jeffrey M. Kenkel, certified plastic surgeon and a spokesman for the coalition of doctors for injectable safety, wrote in an e-mail.
Dr. Phil Haeck, the President of the American Society of plastic surgeons, is concerned about the lack of research demonstrating the efficacy of the Selphyl, that the costs of $900 to $1,500 for a procedure that takes less than half an hour. "There is no scientific study, only certified personal," he said, adding that he thinks that the concept of "creepy" is as outdated as bloodletting to cure the disease. "This is another trick used by the people that stand out on the Internet in a real dog-eat-dog part of medicine."
In addition, doctors and consumers are not clear where is Selphyl with the FDA in a YouTube video with Dr. John Argerson, a doctor of Medicine of family certificate that works of refine MediSpa in Johnson City, Tennessee, tells the consumer Selphyl is a "fill newly approved by the FDA" for the nose to the lip creases. And in an article in December of 2009, Dermatology times, a publication of trade, Dr. Ranella Hirsch, a certified dermatologist, said that selphyl is "A new FDA approved dermal filler". This week, Dr. Hirsch, that does not use Selphyl in their practice, said that she not could explain what she malpronunciando, add in an email that "the lack of clarity between the FDA approval with clearance from the FDA to market is a key point".
In fact. The FDA has not approved or delete P.R.F.M. derived in a centrifuge Selphyl to be marketed for facial rejuvenation. In 2002, the Agency Clears a blood collection system called Fibrinet, whose medical orthopedic plaquetas-ricos by-products will be used to accelerate tissue repair. In 2009, the same team was reborn as Selphyl, and since then, the company promoted as a form of "reverse the natural aging process". This week, Shelly Burgess, a spokesman for the FDA, said that Selphyl manufacturer would have to submit an amendment to obtain the authorization to market its system of collection of blood in a new way, and this amendment was found in this letter.
No comments:
Post a Comment